OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
July 09, 2008
A recent US government study shows that follow-on biologics are likely to have a favorable economic impact if proposed legislation authorizing a regulatory pathway in the US is approved.
July 03, 2008
Richard E. Maleczka Jr. and Milton R. Smith III, professors of the Department of Chemistry at Michigan State University, were recognized by the Environmental Protection Agency's Presidential Green Chemistry Challenge Awards, for designing a catalytic reaction to synthesize precursors for the Suzuki-coupling reaction.
July 02, 2008
A roundtable with John Doney, Jiao Yang, Hans Baer, and Elena Draganoiu.
Natale S. Ricciardi, president of Pfizer Global Manufacturing and senior vice-president of Pfizer, discusses the company's new manufacturing focus that features plant network optimization, increased outsourcing, and greater adoption of agile or lean manufacturing.
The year 2007 was slow for approvals for new molecular entities and overall pharmaceutical industry growth. Big Pharma seeks relief in a growing biologics portfolio.
The pharmaceutical majors invest in biologics production capacity as they advance restructuring programs and build their pipelines